Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 52 articles: HTML format

Single Articles

June 2021
1. MORTMAN KD, Devlin J, Giang B, Mortman R, et al
   Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.
   Am J Clin Oncol. 2021;44:264-268.
   PubMed     Abstract available
   
   
   May 2021
2. TUMINELLO S, Petralia F, Veluswamy R, Wang P, et al
   Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
   Am J Clin Oncol. 2021 May 19. pii: 00000421-900000000-98563.
   PubMed     Abstract available
   
   
   
3. ROH J, Eom JS, Lee MK, Kim J, et al
   Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer: A Multicenter, Retrospective Study.
   Am J Clin Oncol. 2021 May 17. pii: 00000421-900000000-98562.
   PubMed     Abstract available
   
   
   
4. YANG W, Zhang Y, Xia D, Xu X, et al
   The Immunosuppression of Etoposide Deserves Attention in Chemoimmunotherapy.
   Am J Clin Oncol. 2021;44:224-225.
   PubMed    
   
   
   March 2021
5. PARSAI S, Sedor G, Smile TD, Scott J, et al
   Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
   Am J Clin Oncol. 2021;44:126-130.
   PubMed     Abstract available
   
   
   December 2020
6. FARRUGIA MK, Jun S, Hennon MW, Nwogu CE, et al
   Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.
   Am J Clin Oncol. 2020 Dec 1. doi: 10.1097/COC.0000000000000778.
   PubMed     Abstract available
   
   
   November 2020
7. ALPERT N, van Gerwen M, Flores R, Taioli E, et al
   Gender Differences in Outcomes of Patients With Mesothelioma.
   Am J Clin Oncol. 2020;43:792-797.
   PubMed     Abstract available
   
   
   September 2020
8. CLAMON G, Zeitler W, An J, Hejleh TA, et al
   Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.
   Am J Clin Oncol. 2020;43:670-675.
   PubMed     Abstract available
   
   
   
9. YUSUF D, Walton RN, Hurry M, Farrer C, et al
   Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.
   Am J Clin Oncol. 2020;43:615-620.
   PubMed     Abstract available
   
   
   
10. MACARI DM, Gbadamosi B, Jaiyesimi I, Gaikazian S, et al
    Medical Cannabis in Cancer Patients: A Survey of a Community Hematology Oncology Population.
    Am J Clin Oncol. 2020;43:636-639.
    PubMed     Abstract available
    
    
    
11. DONG S, Liang J, Zhai W, Yu Z, et al
    Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.
    Am J Clin Oncol. 2020;43:607-614.
    PubMed     Abstract available
    
    
    July 2020
12. RAPP JL, Tuminello S, Alpert N, Flores RM, et al
    Disparities in Surgical Recommendation for Stage I Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2020 Jul 21. doi: 10.1097/COC.0000000000000740.
    PubMed     Abstract available
    
    
    June 2020
13. VIANI GA, Arruda CV, De Fendi LI
    Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation: A Meta-analysis.
    Am J Clin Oncol. 2020 Jun 16. doi: 10.1097/COC.0000000000000709.
    PubMed     Abstract available
    
    
    
14. CLAMON G, Zeitler W, An J, Hejleh TA, et al
    Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.
    Am J Clin Oncol. 2020 Jun 5. doi: 10.1097/COC.0000000000000720.
    PubMed     Abstract available
    
    
    May 2020
15. YUSUF D, Walton RN, Hurry M, Farrer C, et al
    Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.
    Am J Clin Oncol. 2020 May 29. doi: 10.1097/COC.0000000000000716.
    PubMed     Abstract available
    
    
    
16. NAPOLITANO MA, Skancke MD, Mortman KD
    Analyzing the Time From Discovery to Definitive Surgical Therapy for Lung Cancer Based on Referral Patterns.
    Am J Clin Oncol. 2020 May 1. doi: 10.1097/COC.0000000000000710.
    PubMed     Abstract available
    
    
    April 2020
17. ARORA RK, Gibson AW, Bebb DG, Cheung WY, et al
    The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2020 Apr 28. doi: 10.1097/COC.0000000000000694.
    PubMed     Abstract available
    
    
    March 2020
18. D'ANDREA MA, Reddy GK
    Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
    Am J Clin Oncol. 2020;43:218-228.
    PubMed     Abstract available
    
    
    February 2020
19. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available
    
    
    
20. MARKOVIC SN, Suman VJ, Javed A, Reid JM, et al
    Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU) R
    Am J Clin Oncol. 2020;43:115-121.
    PubMed     Abstract available
    
    
    
21. FIGURA NB, Oliver DE, Mohammadi H, Martinez K, et al
    Novel Dose Escalation Approaches for Stereotactic Body Radiotherapy to Adrenal Oligometastases: A Single-Institution Experience.
    Am J Clin Oncol. 2020;43:107-114.
    PubMed     Abstract available
    
    
    
22. LIN J, Song AJ, Hoffman-Censits J, Leiby BE, et al
    A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.
    Am J Clin Oncol. 2020;43:82-86.
    PubMed     Abstract available
    
    
    January 2020
23. BHANDARI S, Kumar R, Pham D, Gaskins J, et al
    Treatment Timing in Small Cell Lung Cancer, a National Cancer Database Analysis.
    Am J Clin Oncol. 2020 Jan 31. doi: 10.1097/COC.0000000000000676.
    PubMed     Abstract available
    
    
    
24. CHUN SG, Liao Z, Jeter MD, Chang JY, et al
    Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial.
    Am J Clin Oncol. 2020 Jan 27. doi: 10.1097/COC.0000000000000632.
    PubMed     Abstract available
    
    
    
25. WONG JK, Shaikh T, DeMora L, Zhang E, et al
    Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2020 Jan 7. doi: 10.1097/COC.0000000000000662.
    PubMed     Abstract available
    
    
    
26. FATEHI HASSANABAD A, Mina F
    Targeting the Mevalonate Pathway for Treating Lung Cancer.
    Am J Clin Oncol. 2020;43:69-70.
    PubMed     Abstract available
    
    
    December 2019
27. MATSUGUMA H, Nakahara R, Wakamatsu I, Kishikawa T, et al
    Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2019 Dec 16. doi: 10.1097/COC.0000000000000656.
    PubMed     Abstract available
    
    
    
28. ELEGBEDE AA, Gibson AJ, Fu H, Dean ML, et al
    Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.
    Am J Clin Oncol. 2019 Dec 10. doi: 10.1097/COC.0000000000000657.
    PubMed     Abstract available
    
    
    November 2019
29. SUKRITHAN V, Barbaro A, Chergui A, Ko B, et al
    Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2019 Nov 18. doi: 10.1097/COC.0000000000000628.
    PubMed     Abstract available
    
    
    
30. SHARMA A, Mountjoy LJ, Butterfield RJ, Zhang N, et al
    Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Am J Clin Oncol. 2019 Nov 18. doi: 10.1097/COC.0000000000000642.
    PubMed     Abstract available
    
    
    
31. BRAILLON A
    Rural-urban Disparities in Lung Cancer Mortality: Missing the Forest for the Trees?
    Am J Clin Oncol. 2019;42:884-885.
    PubMed    
    
    
    
32. KIM H, Vargo JA, Ling DC, Beriwal S, et al
    Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status.
    Am J Clin Oncol. 2019;42:837-844.
    PubMed     Abstract available
    
    
    
33. NICOLI CD, Sprague BL, Anker CJ, Lester-Coll NH, et al
    On the Importance of Rural Health: Mistaking a Forest for a Few Trees.
    Am J Clin Oncol. 2019;42:885.
    PubMed    
    
    
    
34. IACONO D, Osman GA, Migliorino MR, Grillo L, et al
    Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI Treatment.
    Am J Clin Oncol. 2019;42:845-850.
    PubMed     Abstract available
    
    
    
35. DALWADI SM, Savjani RR, Bernicker EH, Butler EB, et al
    A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC.
    Am J Clin Oncol. 2019;42:851-855.
    PubMed     Abstract available
    
    
    October 2019
36. D'ANDREA MA, Reddy GK
    Extracranial Abscopal Responses in Advanced Lung Cancer Induced by Brain Radiation.
    Am J Clin Oncol. 2019 Oct 30. doi: 10.1097/COC.0000000000000623.
    PubMed     Abstract available
    
    
    July 2019
37. FATEHI HASSANABAD A, McBride SA
    Statins as Potential Therapeutics for Lung Cancer: Molecular Mechanisms and Clinical Outcomes.
    Am J Clin Oncol. 2019 Jul 19. doi: 10.1097/COC.0000000000000579.
    PubMed     Abstract available
    
    
    
38. NICOLI CD, Sprague BL, Anker CJ, Lester-Coll NH, et al
    Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2019;42:607-614.
    PubMed     Abstract available
    
    
    
39. SINGH R, Ansinelli H, Sharma D, Jenkins J, et al
    Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Am J Clin Oncol. 2019;42:602-606.
    PubMed     Abstract available
    
    
    April 2019
40. GUPTA R, Amanam I, Rahmanuddin S, Mambetsariev I, et al
    Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
    Am J Clin Oncol. 2019;42:337-344.
    PubMed     Abstract available
    
    
    March 2019
41. RAPHAEL J, Vincent M, Boldt G, Shah PS, et al
    Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis.
    Am J Clin Oncol. 2019 Mar 25. doi: 10.1097/COC.0000000000000533.
    PubMed     Abstract available
    
    
    January 2019
42. SU CT, Chau V, Halmos B, Shah CD, et al
    Impact of Primary Care Access on Mortality of Lung Cancer Patients in an Underserved Community.
    Am J Clin Oncol. 2019 Jan 16. doi: 10.1097/COC.0000000000000516.
    PubMed     Abstract available
    
    
    
43. MOORE S, Leung B, Wu J, Ho C, et al
    Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2019 Jan 2. doi: 10.1097/COC.0000000000000513.
    PubMed     Abstract available
    
    
    November 2018
44. RATHOD S, Koul R, Bashir B, Chowdhury A, et al
    Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening: A Systematic Review.
    Am J Clin Oncol. 2018 Nov 8. doi: 10.1097/COC.0000000000000489.
    PubMed     Abstract available
    
    
    October 2018
45. KARANTH S, Rajan SS, Revere FL, Sharma G, et al
    Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
    Am J Clin Oncol. 2018 Oct 8. doi: 10.1097/COC.0000000000000485.
    PubMed     Abstract available
    
    
    September 2018
46. GIBSON AJW, Li H, D'Silva A, Tudor RA, et al
    Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2018 Sep 11. doi: 10.1097/COC.0000000000000483.
    PubMed     Abstract available
    
    
    April 2018
47. TUMINELLO S, Liu B, Wolf A, Alpert N, et al
    Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques.
    Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000440.
    PubMed     Abstract available
    
    
    March 2018
48. NIHO S, Ikeda N, Michimae H, Suzuki K, et al
    Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Resear
    Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000438.
    PubMed     Abstract available
    
    
    
49. LAFUENTE-SANCHIS A, Estors-Guerrero M, Zuniga A, Martinez-Hernandez NJ, et al
    Clinical Significance of Molecular Micrometastasis in the Sentinel Lymph Node of Early-stage Non-Small Cell Lung Cancer Patients.
    Am J Clin Oncol. 2018 Mar 5. doi: 10.1097/COC.0000000000000432.
    PubMed     Abstract available
    
    
    January 2018
50. FIORICA F, Belluomini L, Stefanelli A, Santini A, et al
    Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination.
    Am J Clin Oncol. 2018 Jan 31. doi: 10.1097/COC.0000000000000428.
    PubMed     Abstract available
    
    
    November 2017
51. JEREMIC B
    Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).
    Am J Clin Oncol. 2017 Nov 7. doi: 10.1097/COC.0000000000000416.
    PubMed     Abstract available
    
    
    October 2017
52. YOSHIMURA N, Tada T, Matsumoto Y, Sawa K, et al
    Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Fin
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000412.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: